Suchergebnisse - "Oza, Amit M"

PubPharm (340)

1

Disparities in clinical trial enrollment at a Canadian comprehensive cancer center : A 15-year retrospective study

enthalten in: Cancer | 2024

von Shapiro, G. | Santiago, A. | Pittman, T. | +10

2

Antibody-Drug Conjugates : Advancing from Magic Bullet to Biological Missile

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2024

von Veneziani, A. | Sneha, S. | Oza, A.

3

High grade adverse event reporting and enrolment in gynecologic oncology clinical trials

enthalten in: Gynecologic oncology | 2024

von Madariaga, A. | Cole, H. | Pittman, T. | +7

4

Methodical Manipulation of the TME in Ovarian Cancer

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2024

von Soberanis Pina, P. | Oza, A.

CommentOn: Clin Cancer Res. 2024 Jan 5;30(1):176-186. - PMID 37527007

5

Emerging peptide therapeutics for the treatment of ovarian cancer

enthalten in: Expert opinion on emerging drugs | 2023

von Veneziani, A. | Gonzalez-Ochoa, E. | Oza, A.

6

Heterogeneity and treatment landscape of ovarian carcinoma

enthalten in: Nature reviews. Clinical oncology | 2023

von Veneziani, A. | Gonzalez-Ochoa, E. | Alqaisi, H. | +5

7

Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib versus Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian Cancer

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2023

von Grisham, R. | Vergote, I. | Banerjee, S. | +27

8

First-in-human Study of AZD5153, A Small-molecule Inhibitor of Bromodomain Protein 4, in Patients with Relapsed/Refractory Malignant Solid Tumors and Lymphoma

enthalten in: Molecular cancer therapeutics | 2023

von Hamilton, E. | Wang, J. | Oza, A. | +14

9

Treatment of Ovarian Cancer Beyond PARP Inhibition : Current and Future Options

enthalten in: Drugs | 2023

von Garg, V. | Oza, A.

10

Treatment of Ovarian Cancer Beyond PARP Inhibition: Current and Future Options

enthalten in: Drugs | 2023

von Garg, V. | Oza, A.

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[34]